Mold Identification by MALDI-TOF (BRUKER)-Introduction, Principle, Clinical Significance, and Keynotes

by

Introduction

Accurate and timely identification of molds is essential for clinical microbiology, especially in cases of invasive fungal infections caused by Aspergillus, Fusarium, Scedosporium, Mucorales, and other filamentous fungi. Traditional methods based on morphology and phenotypic characteristics are slow, require expertise, and may misidentify cryptic species. Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS), particularly using the Bruker Biotyper system, has emerged as a rapid and reliable method for identifying molds at the species level by analyzing protein spectra, especially ribosomal proteins.

Principle of Mold Identification by MALDI-TOF (BRUKER)

  1. Sample Preparation:
    • Mold colonies are cultured (commonly on Sabouraud agar or similar media) until sufficient growth is achieved.
    • For molds, additional sample preparation steps such as ethanol–formic acid extraction are required to disrupt the tough fungal cell wall.
  2. Ionization & Detection:
    • The extracted proteins are mixed with a matrix solution (commonly α-cyano-4-hydroxycinnamic acid).
    • Laser pulses ionize the matrix–analyte mixture, generating protein ions.
    • Ions travel through the time-of-flight (TOF) analyzer; lighter ions reach the detector faster than heavier ones.
  3. Spectral Analysis:
    • The instrument produces a protein mass spectrum (unique fingerprint).
    • The spectrum is compared against a reference database (Bruker Filamentous Fungi Library, additional in-house spectra).
  4. Identification:
    • Species identification is assigned based on pattern matching with database entries and confidence scoring.

Clinical Significance of Mold Identification by MALDI-TOF (BRUKER)

  • Rapid Identification: Reduces turnaround time from days/weeks (morphology) to hours.
  • Accurate Detection: Identifies clinically relevant molds, including Aspergillus fumigatus, Aspergillus terreus, Fusarium spp., Rhizopus spp., and others.
  • Cryptic Species Recognition: Differentiates closely related or morphologically similar fungi.
  • Improved Patient Outcomes: Enables early initiation of targeted antifungal therapy, reducing morbidity and mortality.
  • Epidemiology & Surveillance: Useful in outbreak investigations and antifungal resistance monitoring.
  • Limitations: Requires good database coverage; sample prep is more complex than yeast identification; may misidentify rare/novel species without proper library updates.

Keynotes

  • Bruker MALDI-TOF MS is a powerful tool for mold identification in clinical microbiology labs.
  • Reliable results depend on optimized sample preparation (ethanol–formic acid extraction).
  • The Bruker Filamentous Fungi Library is continuously expanding, improving identification rates.
  • Faster and more accurate than conventional morphology-based methods.
  • Limited by database completeness and the need for adequate culture growth.
  • Integration with other methods (molecular sequencing, AFST) enhances diagnostic accuracy.

Further Readings

  1. https://pmc.ncbi.nlm.nih.gov/articles/PMC4525378/
  2. https://www.mdpi.com/2076-2607/9/6/1283
  3. https://pmc.ncbi.nlm.nih.gov/articles/PMC8220872/
  4. https://pmc.ncbi.nlm.nih.gov/articles/PMC8220872/
  5. https://www.infectiologyjournal.com/articles/benefits-and-limitations-of-malditof-mass-spectrometry-for-the-identification-of-microorganisms.html
  6. https://onlinelibrary.wiley.com/doi/10.1002/9781683670438.cmph0057
  7. https://www.frontiersin.org/journals/allergy/articles/10.3389/falgy.2022.826148/full
  8. https://www.cdc.gov/fungal/hcp/laboratories/identification-of-molds-using-maldi-tof.html
  9. https://pubmed.ncbi.nlm.nih.gov/38555035/
  10. https://www.researchgate.net/publication/309656676_Identification_of_Molds_by_MALDI-TOF_Mass_Spectrometry
  11. https://pmc.ncbi.nlm.nih.gov/articles/PMC8231132/

Read Also...

Leave a Comment